Stephanie Vrede

CHAPTER 5 118 Figure 3A-C A. B. C. Figure 3 A-C. A. RFS for ESMO-ESGO-ESTRO risk groups and p53-expression. B. RFS for ESMOESGO-ESTRO risk groups and L1CAM-expression C. RFS for ESMO-ESGO-ESTRO risk groups and ER/PR-expression. Abbreviations: ESMO-ESGO-ESTRO, European Society for Medical Oncology - European Society of Gynaecological Oncology - European SocieTy for Radiotherapy & Oncology; p53abn, p53-abnormal; p53wt, p53wildtype; L1CAM, L1 cell-adhesion molecule; ER/PR, estrogen receptor/progesterone receptor; RFS, recurrencefree survival.

RkJQdWJsaXNoZXIy MTk4NDMw